Cytosorbents (CTSO) EBITDA Margin (2011 - 2026)
Cytosorbents (CTSO) recorded EBITDA Margin of -23.65% in Q2 2026, up 10.40 percentage points from -34.05% a year earlier and up 6.18 percentage points from the prior quarter.
Powered by 
Analysis
Cytosorbents (CTSO) EBITDA Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Cytosorbents' EBITDA Margin came in at -31.13% as of Jun 30, 2026, up 8.70 percentage points year-over-year; for FY2025, it came in at -35.76%, up 6.05 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -12.08 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -41.81% in FY2024 (+56.28 pp), -98.08% in FY2023 (-9.76 pp), -88.33% in FY2022 (-37.33 pp) and -51.00% in FY2021 (-27.32 pp).
- The Q2 2026 figure is the highest quarterly EBITDA Margin since Q4 2020.
- On a year-over-year basis, EBITDA Margin rose in seven of the last eight quarters, with an average year-over-year change of +17.64 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 68.61 percentage points in Q4 2024, against a drop of 66.05 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -29.83% (Q1 2026), -46.44% (Q4 2025) and -25.03% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 253.17 Bn | 232.20 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 175.66 Bn | 146.09 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 163.70 Bn | 147.51 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 154.98 Bn | 134.40 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 121.35 Bn | 86.60 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 116.85 Bn | 102.96 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 66.54 Bn | 61.31 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 54.13 Bn | 51.28 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 51.52 Bn | 35.53 Bn | 1.35 Bn | 31.93% |
| 10 | Cytosorbents | 19.41 Mn | -3.60 Mn | 7.05 Mn | -20.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.72% |
| Mar 31, 2026 | -26.55% |
| Dec 31, 2025 | -43.74% |
| Sep 30, 2025 | -23.03% |
| Jun 30, 2025 | -32.06% |
| Mar 31, 2025 | -37.01% |
| Dec 31, 2024 | -34.03% |
| Sep 30, 2024 | -51.10% |
| Jun 30, 2024 | -35.32% |
| Mar 31, 2024 | -46.87% |
| Dec 31, 2023 | -99.43% |
| Sep 30, 2023 | -78.17% |
| Jun 30, 2023 | -64.77% |
| Mar 31, 2023 | -80.19% |
| Dec 31, 2022 | -64.72% |
| Sep 30, 2022 | -107.75% |
| Jun 30, 2022 | -94.92% |
| Mar 31, 2022 | -86.40% |
| Dec 31, 2021 | -83.00% |
| Sep 30, 2021 | -52.96% |
API Access
Cytosorbents EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CTSO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CTSO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CTSO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();